Abbott Laboratories Hits Day High with Strong 3.07% Intraday Surge

Abbott Laboratories has experienced a notable uptick in its stock performance, gaining 3.07% on June 23, 2026. The stock reached an intraday high of USD 90.92, reflecting a significant moment in its trading activity. This performance stands in contrast to the S&P 500, which declined by 1.44% on the same day. Over the past month, Abbott Laboratories has shown resilience with a 3.57% increase, while the S&P 500 has faced a decline of 1.45%. However, the company has encountered challenges over the longer term, with a year-to-date performance down by 27.74% compared to the S&P 500's gain of 7.6%. Abbott Laboratories maintains a strong financial position, highlighted by a low Debt to EBITDA ratio of 0.62 times and a robust operating profit growth rate of 13.45% annually. The company has reported positive results for the last three consecutive quarters, showcasing its operational strength. With a market capitalization of USD 203,040 million, Abbott Laboratories continues to navigate the pharmaceuticals and biotechnology landscape with a solid foundation.